Eutelsat Comms (OTC:ETCMY) Stock, Quote.Headers.trade-ideas

Eutelsat Communications is a French commercial satellite provider with coverage spanning the European continent, the Middle East, Africa, India, and the Americas. It operates a fleet of over 36 satellites serving broadcasters, telecommunications operators, Internet service providers, and government agencies. These satellites are used for video broadcasting, news gathering, broadband services, and data connectivity solutions. Eutelsat generates revenue in Europe, the Americas, the Middle East and North Africa, and Asia.

News

Penny Stocks

Tech

Media

AMZN

ETCMY

TSLA

Eutelsat, OneWeb Brace To Unite To Compete SpaceX: Report

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAVMY

AEGY

AFOM

ALRM

AMCX

APPB

APYP

ARLP

ASTVF

ATOXF

AVLIF

BGRDF

BKEAF

BLILF

BOCH

BOSC

BRVO

BSAC

BTCS

BYDDY

CDEV

CFPUF

CHLKF

CIRX

CKPT

CLPHF

CPNFF

CTEQF

CTRA

CTST

CUII

CVSI

CVTI

CWGL

CXUS

DNAX

DREAM HOMES & DEV CORP by Dream Homes & Development Corporation

DREM

DRRSF

DRWIQ

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENBL

ENLC

ETRN

EXTN

FRONTERA ENERGY CORP ORD by Frontera Energy Corp

FECCF

FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc.

FFRMF

FLOOF

FPAFY

GBLTF

GDYMF

GLOP

GMLP

GXOCF

ICNAF

IMMR

IVOB

IWSY

JASN

KOIOS BEVERAGE CORP by Koios Beverage Corp.

KBEVF

KGET

LCUT

LKSD

LNVGY

LORL

LIFE'S TIME CAPSULE SRVS by Life's Time Capsule Services, Inc.

LTCP

MCPH

MIXT

MJARF

MOGU

MRMD

MVVYF

NAPRF

NBEV

NEON

NKRKY

NTGN

NTGR

NVEE

NWSGY

PCCYF

PIEJF

Stocks That Hit 52-Week Lows On Tuesday

EUTELSAT COMMUNS SA S/ADR by Eutelsat Communications

Eutelsat Communications

MIND Technology, Inc. ("MIND" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) announced today that its Seamap unit has received an order for a GunLink source controller amounting to approximately $5.1 million.&nbsp; Subsequent to July 31, 2024, the Company has received orders totaling approximately $7.9 million.
Mark Welker, Vice President of MIND and Seamap Managing Director, stated, "We are seeing strong demand for our GunLink source controllers. These most recent orders indicate the continuing demand across our family of source controller products. We expect to deliver a portion of these orders in this fiscal year; however, the majority will be delivered in our next fiscal year.&nbsp; In addition to the orders that we have in hand, we are pursuing a number of significant opportunities that we expect to bring to fruition in the coming weeks and months. We think our continuing backlog and pipeline of business bodes well for the balance of this fiscal year and next year as well."

MIND

MIND Technology's Seamap Unit Secures $5.1M GunLink Order, Expands Total to $7.9M

Biotech

Health Care

SKYE

Skye Bioscience Comments Regarding A Recent Announcement By Novo Nordisk On Phase 2a Topline Data With Monlunabant And, Reiterates Confidence In Its Nimacimab Clinical Development Plan, Says 16-week Top-line Weight Loss Data Validates Mechanism Of Action Targeting Peripheral CB1 Receptors

Federal Reserve

Minneapolis Fed President Kashkari Said Balance Of Risks Have Shifted Toward Risk Of Further Labor Market Weakening, Higher Unemployment; 50 BPS Rate Cut Was Right Decision, Reflects Progress On Inflation, Softening Of Labor Market

Invivyd, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today provided detailed virology data supporting previously communicated neutralization activity results, along with a genetic and structural analysis of past and present SARS-CoV-2 variant spike proteins, including the established molecular target of pemivibart.
As part of Invivyd's ongoing monitoring of antiviral activity, Invivyd contracts with LabCorp's Monogram Biosciences lab to provide independent, robust virology assessments in a consistent lineal chain that allows for consideration of potential changing pemivibart potency as SARS-CoV-2 evolves. Pemivibart potency against contemporary viruses KP.3.1.1 and LB.1 remains in-line with the totality of predominant variants dating back to 2022, including isolates identified during the conduct of the CANOPY Phase 3 clinical trial from late 2023 to early 2024. Data Table 1, below, provides relevant comparative values drawn from the PEMGARDA Healthcare Providers Fact Sheet.
"Quantitative neutralization assays exhibit marked intrinsic variability. Since discovery, pemivibart has exhibited impressively stable neutralization results across a wide range of SARS-CoV-2 variants, including and through contemporary variants tested," said Robert Allen, Ph.D., Chief Scientific Officer of Invivyd. "The values we observe thus far generally fall within the expected variability of the assay systems we employ."&nbsp;&nbsp;
Invivyd also provided an update to ongoing structural analysis showing no meaningful mutational change in the pemivibart binding site since the Omicron shift late in 2021. These data are presented in Figure 1 below. The pemivibart binding site is defined as a region of amino acid residues on the spike protein within 5 angstroms (5 Å) of the interaction between pemivibart and spike protein in a crystal structure and consists of 19 key amino acids. Invivyd's ongoing genetic and structural analyses of these residues provide the underlying biological rationale for the company's ongoing expectation for neutralization activity of pemivibart in the face of constant and convergent mutation in the SARS-CoV-2 spike protein. Analysis to date of all 19 amino acids presented below shows de minimis mutational change with ongoing stability to the binding site since the Omicron shift.
"To stay ahead of the curve, it is necessary to integrate data across multiple sources, including clinical and wastewater surveillance, as well as functional genomics. Invivyd's work over the last few years has achieved exactly that," said Kristian Andersen, Ph.D., a professor in the Department of Immunology and Microbiology at Scripps Research and member of Invivyd's scientific advisory board. "Continued surveillance of SARS-CoV-2 evolution is critically important to ensure that we can effectively counter the threat posed by the virus."

IVVD

Invivyd Shares New Data on Pemivibart's Neutralization of COVID Variants, Details Virus Evolution

U.S. index futures are modestly higher at the start of a new week as the rate cut euphoria fades and traders look ahead to the next key catalysts. The tech space could get a lift from <a href="https://www.benzinga.com/news/24/09/40975507/intels-stock-gains-in-pre-market-trading-following-reports-of-qualcomms-and-apollos-investment-offer">a potential lifeline for struggling Intel Corp.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and traders may also look ahead to Micron Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) earnings report due later this week. FedEx Corp.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) annual shareholder meeting and conference presentations by companies could also be on traders&#8217; radar.
A few Fed speeches and private sector activity data due on Monday will also be of interest to the market, which has had an atypically strong September. China followed up with more cuts on Monday as the country strives to bring the struggling economy back on track.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.24%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.15%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.06%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.32%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Monday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.15% to $569.09 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) climbed 0.27% to $483.06, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Week:
U.S. stocks recorded gains for the second straight week as the Fed&#8217;s 50 basis-point cut set the market on fire, although a session after the announcement. After a mixed start to the week, positive retail sales generated buying interest in the market on Tuesday. Sentiment soured on Wednesday despite the initial positive reaction to the rate cut and the major indices closed lower. 
Traders reacted with a lag to the rate cut, sending averages sharply higher on Thursday. The S&amp;P 500 Index and the Dow Jones Industrial Average scaled record highs in the session. Caution returned on Friday as the market closed the triple-witching session on a mixed note. The Dow built on its gains on Friday and ended at a new high.
&#8220;This might be a September rally to remember on Wall Street, as history is not on the side of September delivering many market rallies,&#8221; said fund manager Louis Navellier.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Weekly Performance (+/)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+1.50%</td>
<td>17,948.32</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+1.36%</td>
<td>5,702.55</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+1.62%</td>
<td>42,063.36</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>+2.08%</td>
<td>2,227.89</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
The atypical September rally points to more gains ahead before the year ends, says Carson Group&#8217;s Chief Market Strategist Ryan Detrick. A new high for the S&amp;P 500 Index in September has meant an even better fourth quarter in the past, he said. The market has risen 19 out of 21 times and the average gain is nearly 5%, he said. If the new high was made in September, which also happens to be an election year, the fourth quarter is higher 100% of the time with an average gain of 6%.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When the S&amp;P 500 makes a new high in September (like &#39;24) it appears Q4 does even better. In fact, higher 19 out of 21 times (90.4%) and up nearly 5% on avg. New highs in Sept of election year? Q4 higher 6 out of 6 and up nearly 6% on avg.
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1837903370494820836?ref_src=twsrc%5Etfw">September 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The S&amp;P 500 Index, which closed Friday&#8217;s session, just shy of an all-time high, is now above year-end price predictions of 70% of Wall Street analysts. This has rendered S&amp;P valuation slightly higher than the average number for the past five and past 10 years, FactSet data showed.
JPMorgan Global Investment Strategist&nbsp;Sarah Stillpass&nbsp;said in a report the September rate cut could bode well for equities. Since 1980, five of the 10 best years for the S&amp;P 500 happened when the Fed was cutting rates without a recession, she said. She also noted that the Fed has cut rates 12 times when the S&amp;P 500 was within 1% of its all-time high such as the current year. The market was higher one year later all 12 times, with a median return of 15%, she added.
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Upcoming Economic Data:
A slew of Fed speeches and the core personal consumption expenditure index, which is part of the personal income and spending report, are the key data the market will likely look forward to in the unfolding week. Traders may also keep a close eye on the weekly jobless claims data, flash private sector activity readings from S&amp;P Global, a consumer confidence reading, the August durables goods orders data and a couple of housing market readings.
On Monday, Atlanta Fed President Raphael Bostic is scheduled to speak at 8 a.m. EDT, followed by Chicago Fed President Austan Goolsbee at 10:15 a.m. EDT and Minneapolis Fed President Neel Kashkari&nbsp;at 1 p.m. EDT.
S&amp;P Global will release its flash manufacturing and service sector purchasing managers&#8217; indices for September at 9:45 a.m. EDT. Economists, on average, expect the manufacturing purchasing managers&#8217; index to rise from 47.9 in August to 48.4 in September, suggesting the sector continued to contract. The service sector PMI is widely expected to hold steady at 55.4 compared to August&#8217;s 55.7.
The Treasury will auction three- and six-month notes at 11:30 a.m. EDT.
Stocks In Focus:
<ul>
<li>Intel rose about 3% <a href="https://www.benzinga.com/premarket">in premarket trading</a> amid reports that Apollo Global Management seeks to invest $5 billion in the chipmaker in return for an equity stake in the company. Incidentally, Qualcomm, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) is rumored to be interested in buying Intel.</li>
<li>Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rally is sending crypto-linked stocks higher on Monday.</li>
<li>Palantir Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) fell over 1.60% following a negative analyst action. The company will be added to the S&amp;P 500 Index, along with Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and Erie Indemnity Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>).</li>
<li>AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) is due to <a href="https://www.benzinga.com/calendars/earnings">announce its quarterly results after the market closes.</a></li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil and gold futures are modestly higher, with the latter trading near record territory. Bitcoin has gone past the $63.5K level. The 10-year Treasury note yield rose 1.1 points to 3.739%.
The Asian markets closed on a lackluster note, although the Japanese market remained closed for a public holiday. The People&#8217;s Bank of China announced a cut to its 14-day reverse repurchase rate, following up with the downward adjustments that began in July. Chinese central bank governor Pan Gongsheng will hold a press conference Tuesday on financial support for economic development, alongside two other officials, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-09-23/china-announces-another-rate-cut-as-growth-slowdown-worsens">reported.</a>
European stocks also showed tentativeness as domestic traders digested weak private sector activity data from the region.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40974885/s-p-500-outpaces-wall-street-projections-as-year-end-nears-will-the-rally-hold">S&amp;P 500 Outpaces Wall Street Projections As Year-End Nears: Will The Rally Hold?</a></li>
</ul>
Photo via Shutterstock

Earnings

Equities

Futures

Previews

Economics

Pre-Market Outlook

$BTC

DELL

ERIE

INTC

PLTR

QCOM

Wall Street Eyes Modestly Positive Start As Atypical September Rally Generates Positive Sentiment, China Cuts Rate: Intel, Palantir, Bitcoin Make Huge Moves

<ul>
<li>Riot has agreed to withdraw its June 24, 2024 requisition, as amended, and to accept customary standstill provisions through the Bitfarms 2026 Annual Meeting, with certain exceptions.</li>
<li>The Company has provided Riot with certain rights (subject to certain exceptions) to purchase shares of the Company provided Riot holds&nbsp;15%&nbsp;or more of the outstanding common shares of the Company.</li>
</ul>

Management

BITF

RIOT

Bitfarms, Riot Platforms Enter Settlement Agreement In Advance Of Special Meeting; Andrés Finkielsztain Has Stepped Down From Bitfarms' Board, Amy Freedman To Join Board

ALKS

Alkermes Announced Plans To Present Clinical Data From Its Phase 1B Study Of ALKS 2680 In Patients With Narcolepsy Type 2 And Idiopathic Hypersomnia At The European Sleep Research Society Congress, Sleep Europe 2024

MoffettNathanson analyst Michael Nathanson initiates coverage on Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Neutral rating and announces Price Target of $100.

Price Target

Initiation

Analyst Ratings

MoffettNathanson Initiates Coverage On Trade Desk with Neutral Rating, Announces Price Target of $100

<a href="https://www.globenewswire.com/Tracker?data=r4RuL-g8BiKVZqLRnMl8EGgAMp3MEvcuP1lhTYpiuoJgsZ1jahk_eeysIWLnQ1bAlIACdbq5BXPKTE0CscTH9fs6bHnXyXzwYWhIPkSFsL0=">Black Diamond Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today reported initial Phase 2 data demonstrating encouraging clinical responses and durability of BDTX-1535 in patients with relapsed/refractory epidermal growth factor receptor (EGFR)-mutant (EGFRm) non-small cell lung cancer (NSCLC).
"Patients often become resistant to osimertinib with the emergence of on-target resistance EGFR mutations," said Sergey Yurasov, M.D., Chief Medical Officer of Black Diamond Therapeutics. "Our preliminary Phase 2 data demonstrate the potential of BDTX-1535 to deliver durable responses for these patients."
"Patients with recurrent EGFRm NSCLC have few treatment options, with chemotherapy delivering limited benefit and significant toxicity, and initial Phase 2 data with BDTX-1535 look quite promising," said Danny Nguyen, M.D., <a href="https://www.globenewswire.com/Tracker?data=vlr3UZ7jREPq-nVuV_0_0C88uBRItoG_u2Pds2FLZhl6OdG7j4DTPUFysQY2y_LIjwyzqAqfOfpni53hE75snJRWUiN0k0RirbHBhXGxPKYSET-VNVVUwbCm2cnWyEzenhj0xWJvWFDh1oHU2wzxnXLBK7T4WBCokjmhe7dQL7lQDcWhMG63hpBMKrSRhrsiyEiYvQrw6wRSj8xyaeufaSI2us8FlQDhdtCYWaPgkus=">Assistant Clinical Professor, Department of Medical Oncology and Therapeutics Research at City of Hope</a>. "There is a significant unmet medical need for an effective and well-tolerated oral therapy for patients who progress on osimertinib, as well as newly diagnosed patients with non-classical mutations."
Phase 2 preliminary data overview:
The phase 2 trial began in August of 2023, and enrolled relapsed/refractory patients with non-classical EGFR mutations (NCMs) (Cohort 1) and those with C797S resistance mutations (Cohort 2). Safety assessment and dose selection were based upon the first 40 patients randomized to receive BDTX-1535 once daily at either 100 mg or 200 mg across both Cohorts. Preliminary response rate and durability were assessed in 27 patients at 200 mg with an August 17, 2024, data cutoff, including 22 response-evaluable patients who met protocol eligibility criteria.
Key takeaways:
<ul>
<li>200 mg daily selected for pivotal clinical development. Dose selection was based primarily on pharmacokinetics, safety and tolerability data from 20 patients at 100 mg, and 20 patients at 200 mg.</li>
<li>Favorable tolerability profile at 200 mg, consistent with prior BDTX-1535 clinical data. The majority of adverse events were mild or moderate, and no new safety signals were observed. The most common on-target treatment-related adverse events were rash (70%) and diarrhea (35%). There were 2 cases of grade 3 rash, and no reported cases of grade 4 rash or grade 3/4 diarrhea.</li>
<li>Preliminary objective response rate (ORR) of 42% achieved in 19 patients. For the 22 response-evaluable patients, the preliminary ORR was 36%. Nineteen of these 22 patients expressed known osimertinib resistance mutations: either C797S or P-loop alpha-C helix compressing (PACC, a major subset of NCMs). Of these 19 patients, 8 achieved a response (42%): 5 with a confirmed partial response (PR), including 1 patient who converted from a PR to an unconfirmed complete response (CR) at 8 months (and awaits confirmatory scan); and 3 with an unconfirmed PR at first scan and awaiting a confirmatory scan. An additional 9 patients experienced stable disease.</li>
<li>Encouraging durability observed, with duration of response (DOR) of approximately 8 months or more for first 3 patients with PR; 14 of 19 patients remain on therapy. Mean follow-up time is 4.7 months.</li>
</ul>
"We are pleased to see significant Phase 2 clinical activity and tolerability that are consistent with our Phase 1 results," said Mark Velleca, M.D., Ph.D., Chief Executive Officer of Black Diamond Therapeutics. "We believe that the activity observed in the recurrent setting can translate to robust clinical benefit in the first-line setting, and we look forward to sharing data from our trial in newly diagnosed patients in Q1 2025."
Black Diamond continues to enroll patients in the second- and third-line cohorts, as well as in the first-line setting for patients with non-classical EGFR mutations. In Q1 2025, the Company expects to disclose initial results from the first-line cohort and to outline potential registrational paths in the recurrent setting based on FDA feedback.

Government

Regulations

BDTX

Black Diamond Reports Phase 2 Results for BDTX-1535 in Lung Cancer, Targets FDA Approval Path

Lead investors, Delta Air Lines, Inc.,&nbsp;CK&nbsp;Wheels&nbsp;LLC, and Cox&nbsp;Investment Holdings,&nbsp;LLC, agreed to extend the lock-up restriction with respect to all their shares of common stock&nbsp;issued under the Investment and Investor Rights Agreement, for an additional year, until September&nbsp;20,&nbsp;2025.
In addition, Kore Capital LLC and funds managed by Whitebox&nbsp;Advisors LLC, agreed to extend the lock-up restriction with respect to&nbsp;72.5%&nbsp;of their shares until September&nbsp;20,&nbsp;2025.

Wheels Up Says Approximately 97.2% Of Lead Investor Shares Will Remain Subject To The Lock-up Restriction Until September 20, 2025

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>), the world's trusted infrastructure consulting firm, today announced its selection by the City of Austin as the prime consultant for the expansion of the Walnut Creek Wastewater Treatment Plant (WWTP) in Austin, Texas. The project aims to improve the aging structure's operational and environmental features by increasing the plant's capacity from 75 million gallons per day (MGD) to 100 MGD. As the population of Austin grows, the upgrades will bolster the resiliency of the community's wastewater infrastructure while safeguarding its surrounding ecosystem.
"As our industry's leading Water consulting firm, we look forward to continuing our long-standing partnership with the City of Austin to ensure the Walnut Creek Expansion delivers state-of-the-art treatment capabilities to the local community," said Beverley Stinson, chief executive of AECOM's global Water business. "Our teams have established themselves as pioneers in the global push to advance highly efficient and cost effective nutrient removal, and will leverage this extensive expertise to enhance the plant and improve the effluent water quality to protect the environment, while meeting existing and future community demands."
The AECOM team's scope of work for the project includes process, mechanical, civil, electrical and structural engineering services to modernize and upgrade the existing infrastructure, while incorporating advanced operational and environmental features. The expansion will involve replacing aging equipment, constructing a new 25 MGD treatment train, and building a new 120-inch outfall line and structure. The project will also provide wet weather treatment with new 100 MGD cloth filters and build a flood wall to protect against 100-year floods in accordance with the National Weather Service's historic <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.austintexas.gov%2Fdepartment%2Fflood-risk-and-atlas-14&amp;esheet=54125161&amp;newsitemid=20240923628017&amp;lan=en-US&amp;anchor=Atlas+14&amp;index=1&amp;md5=f42d51c75c9b61534bc111d8082f631f">Atlas 14</a> flood risk study.
"AECOM has a longstanding partnership with the City of Austin, having designed substantial portions of the City's major water and wastewater treatment plants," said Matt Crane, chief executive of AECOM's U.S. West region. "Our expertise in complex treatment design will support an exceptionally resilient, sustainable facility, aligning with our Sustainable Legacies strategy to make a lasting positive impact through every project we undertake."
Originally built in 1977 with an 18 million gallon per day capacity, the Walnut Creek Wastewater Treatment Plant has since been expanded three times in 1987, 1990, and 2005 to reach its current capacity of 75 million gallons per day. The facility is expected to remain operational throughout the work.

AECOM to Lead Major Expansion of Austin's Walnut Creek Wastewater Plant, Boosting Capacity to 100 MGD

Tempur Sealy International, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPX#NYSE">TPX</a>, ", Company", or ", Tempur Sealy", )))) today provided an update with respect to the Company's agreement to acquire Mattress Firm Group Inc. ("Mattress Firm"), which is currently being challenged in federal court by the Federal Trade Commission ("FTC").
The litigation process continues to progress, with hearings currently scheduled to begin on November 12, 2024, and expected to last two weeks. The Company continues to believe that a successful litigation process can be completed in the coming months, which would allow the transaction to close in late 2024 or early 2025, consistent with previous expectations.
In conjunction with the planned Mattress Firm acquisition, Tempur Sealy has entered into a purchase agreement with MW SO Holdings Company, LLC ("Mattress Warehouse"), a leading independently owned bedding specialty retailer, for the sale of 73 Mattress Firm retail locations and the Company's Sleep Outfitters subsidiary, which includes 103 specialty mattress retail locations and seven distribution centers.
Mattress Warehouse is a multi-branded retailer offering a full array of mattresses at various price points. Tempur Sealy will continue to supply its Tempur-Pedic, Stearns &amp; Foster, and Sealy products to the divested Mattress Firm and Sleep Outfitters stores. The divestiture is subject to the closing of Tempur Sealy's acquisition of Mattress Firm and other customary closing conditions. It is expected to close approximately one quarter after the closing of the Mattress Firm transaction.
Company Chairman and CEO Scott Thompson commented, "As part of our engagement with the FTC on the proposed acquisition of Mattress Firm, we conducted a divestiture process, which led to an agreement with Mattress Warehouse, a company with extensive mattress retail experience, a strong capital base, and a capable leadership team."

Tempur Sealy Moves Forward with Mattress Firm Acquisition, FTC Court Hearings Set for November

Tempur Sealy intends to use the proceeds from the Term Loan B, together with cash available and proceeds from other debt, to fund the cash consideration for the previously announced acquisition of Mattress Firm Group Inc.. Tempur Sealy intends to draw on the Term Loan B concurrent with the closing of the Mattress Firm acquisition.

Tempur Sealy Launches Proposed Senior Secured Term Loan B Facility In An Aggregate Principal Amount Of Up To $1.6B

Keybanc analyst Jackson Ader maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Overweight and raises the price target from $300 to $345.

CRWD

Keybanc Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $345

Keybanc analyst Sangita Jain maintains Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Overweight and raises the price target from $230 to $265.

Keybanc Maintains Overweight on Constellation Energy, Raises Price Target to $265

Keybanc analyst Steve Barger maintains Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) with a Overweight and raises the price target from $215 to $245.

Keybanc Maintains Overweight on Applied Industrial Techs, Raises Price Target to $245

The&nbsp;Committee for Medicinal Products for Human Use (CHMP)&nbsp;of the European Medicines Agency based its positive opinion on results from the MANDARA Phase III trial published in&nbsp;The New England Journal of Medicine, which compared the efficacy and safety of&nbsp;Fasenra&nbsp;to the only approved EGPA treatment, mepolizumab, in patients with relapsing or refractory EGPA.
MANDARA was the first head-to-head non-inferiority trial of biologics in patients with EGPA. Patients were randomized to receive either a single 30 mg subcutaneous injection of&nbsp;Fasenra, or three separate 100 mg subcutaneous injections of mepolizumab every four weeks.

Large Cap

AstraZeneca's Fasenra (Benralizumab) Has Been Recommended For Approval In The European Union As An Add-on Treatment For Adult Patients With Relapsing Or Refractory Eosinophilic Granulomatosis With Polyangiitis

SpaceX CEO Elon Musk said on Monday that there are <a href="https://www.benzinga.com/news/24/09/40967983/spacex-pushes-ahead-with-fifth-starship-test-flight-preparation-despite-no-faa-launch-approvals-in-s">multiple regulatory hurdles</a> to launching a rocket, including getting clearance from the U.S. Fish and Wildlife Service.
What Happened: &#8220;We need multiple Fish licenses to launch a rocket (actually)!,&#8221; Musk wrote on social media platform X, referring to clearance from the United States Fish and Wildlife Service required ahead of space missions confirming that the operations will not impact surrounding wildlife.
The CEO was responding to a snippet of his interview with Lex Fridman from November 2023 where he said, &#8220;Currently, the limiting factor for SpaceX, for Starship launch, is regulatory approval.&#8221;
&#8220;I don&#8217;t think the public is quite aware of the madness that goes on,&#8221; Musk then said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need multiple Fish licenses to launch a rocket (actually)! <a href="https://t.co/K9zj0EqyTZ">https://t.co/K9zj0EqyTZ</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1838089797224497250?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Earlier this month, SpaceX said in a blog post that the delay in getting regulatory approvals for the fifth test flight of its ambitious Starship, despite the launch vehicle being ready, is because the Federal Aviation Administration is consulting with the U.S. Fish and Wildlife on the impact of the proposed flight on surrounding wildlife, among other reasons. 
On Sunday, Musk also raised concerns about the Starship program getting &#8220;smothered&#8221; by government bureaucracy. The bureaucracy is rising and the regulatory red tape is affecting all large projects in America, the CEO said. 
The regulations, Musk previously said, <a href="https://www.benzinga.com/news/24/09/40812203/elon-musk-warns-spacexs-efforts-to-make-life-multiplanetary-would-be-effectively-illegal-without-maj">will intensify </a>if Kamala Harris is elected President in the upcoming elections. While Republican Donald Trump has expressed willingness to initiate a government efficiency commission aimed at reducing regulations, the red tape would only rise under a Democratic party administration, Musk opined.
Why It Matters: Musk on Sunday also said that SpaceX intends to launch about five uncrewed Starships to Mars in two years, elaborating on his timeline from earlier this month.
If the five uncrewed missions land safely, crewed missions will be&nbsp;<a href="https://www.benzinga.com/news/24/09/40972893/trumps-mars-landing-promise-gets-slammed-by-peter-schiff-even-as-elon-musk-says-spacex-plans-5-launc" target="_blank" rel="noreferrer noopener">possible in four years</a>, Musk said. However, in case of challenges, the crewed missions will be postponed another two years, he added, pegging crewed Starship missions to Mars for as early as 2028 and latest by 2030.
However, the Starship has undergone only four test flights to date, and Musk has previously made tall claims about the Starship&#8217;s readiness. Musk aims to take humans to Earth&#8217;s orbit, the Moon, and Mars with the spacecraft. 
However, Musk&#8217;s SpaceX has been increasing its launch frequency with its Falcon launch vehicles alone. Earlier this month, the company launched its <a href="https://www.benzinga.com/news/24/09/40916098/elon-musks-spacex-launches-90th-mission-in-2024-with-over-a-third-of-launch-target-still-to-go">90th mission for the year</a> with its Falcon 9 workhorse accounting for a majority of the launches. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="ttps://www.benzinga.com/news/24/09/40973892/unifor-members-at-gms-cami-assembly-and-battery-assemble-plants-secure-new-contract-with-pay-increas">Unifor Members At GM&#8217;s CAMI Assembly And Battery Assemble Plants Secure New Contract With Pay Increases</a></li>
</ul>
Image Via Shutterstock

SPACE

Elon Musk Shares It Takes 'Multiple Fish Licenses' To Launch A Rocket: 'I Don't Think The Public Is Quite Aware Of The Madness That Goes On,' Says SpaceX CEO

<a href="https://americanbatterytechnology.com/">&nbsp;American Battery Technology Company</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, has been <a href="https://www.energy.gov/mesc/bipartisan-infrastructure-law-battery-materials-processing-and-battery-manufacturing-recycling">selected for a highly competitive grant for $150 million</a> dollars of federal investment&nbsp;by the U.S. Department of Energy to be applied towards the construction of a new lithium-ion battery recycling facility.
&nbsp;
This facility will be the company's second commercial-scale lithium-ion battery recycling facility and is designed to process approximately 100,000 tonnes of battery materials per year from its battery manufacturer, automotive OEM, and community partners.
"We are extremely honored to be selected for this government investment to further expand our domestic battery recycling operations, and after having gone through nearly one-year of technical and economic evaluation, we appreciate the level of diligence that the government employed in making this decision," stated ABTC CEO Ryan Melsert. "We are greatly appreciative of the confidence and support we have received from our partners throughout this process and are energized to move forward with our feedstock supply, product offtake, and strategic stakeholders in this critical expansion of our domestic capabilities."
True to the company's strategic model to engage a diverse portfolio of partners and stakeholders to bring advanced battery technologies online and establish a commercial battery metals supply chain for North America, this project will leverage multiple partners including feedstock supplier and critical mineral product offtaker BASF, global engineering firm Siemens, the Clemson University International Center for Automotive Research (CU-ICAR), the Argonne National Laboratory (ANL) ReCell Center, the Argonne National Laboratory Sustainable Transportation Education &amp; Partnerships (STEP) department, and the South Carolina Electric Transportation Network (SCETNetwork). &nbsp;
ABTC constructed and commissioned its first lithium-ion battery recycling facility near Reno, Nevada in Fall 2023, which implements its internally-developed processes for the strategic de-manufacturing and targeted chemical extraction of battery materials in order to manufacture battery grade products at competitive costs and with low environmental footprint.&nbsp; These processes are fundamentally different than conventional methods of battery recycling, which generally utilize either high temperature smelting or non-strategic shredding systems.
Through this new facility construction project, ABTC will employ a proactive, community-driven engagement model to build an energy equity, sustainable circular manufacturing ecosystem that aims to create 1,200 construction jobs and 300 operations jobs. The company will work in direct partnership between communities, educational institutions, industry, government, the National Laboratory system, and the next generation workforce to support equitable and sustainable initiatives that benefit and strengthen in local communities, including in underserved communities that have historically been left behind.
ABTC is partnering with government entities and local educational institutions, such as ANL's STEP department and Clemson University, to create career pathways in battery recycling and establish a talent pipeline for the domestic battery recycling industry.
Bringing first-of-kind technologies to market,&nbsp;ABTC's battery recycling and primary battery metals commercialization efforts support the buildout of a domestically-sourced battery metals circular supply chain.&nbsp; ABTC has been selected for several competitive awards supporting the advancement and commercialization of its first-of-kind technologies for both battery recycling and primary claystone-to-lithium hydroxide manufacturing.&nbsp; &nbsp; U.S. DOE Investments in ABTC Lithium-Ion Battery Recycling&nbsp;
<ul>
<li>October 2021: ABTC was awarded a competitive grant for a <a href="https://americanbatterytechnology.com/projects/usabc-project/">$2 million project</a> from the United States Advanced Battery Consortium (USABC) supported by funding from US DOE to foster the recycling of battery packs and extraction of battery metals, with USABC cost contributions of $500k.</li>
<li>November 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was awarded for a competitive grant for a $20 million project from the U.S. DOE to scale</a>, optimize, and commercialize three next generation technologies to even further enhance the performance of its recycling operations, with a federal contribution of $10 million.</li>
<li>March 2024:<a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-20-million-tax-credit-through-competitive-us-doe-process-to-advance-its-critical-minerals-battery-recycling-facility/"> ABTC awarded qualifying advanced energy project tax credits (48C) for $20 million</a> to be applied towards capital expenditures of its first battery recycling facility near Reno, Nevada.</li>
<li>March 2024: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-additional-40-million-competitive-tax-credit-to-accelerate-construction-of-next-battery-recycling-facility/">ABTC awarded qualifying advanced energy project tax credits (48C) for $40 million</a> to be applied towards capital expenditures of its second battery recycling facility.</li>
<li>TBD 2025: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was selected for this competitive grant for a $150 million project from the U.S. DOE to construct a second battery recycling facility</a>.</li>
</ul>
U.S. DOE Investments in ABTC Lithium Hydroxide (LiOH) from Claystone Manufacturing&nbsp;
<ul>
<li>October 2021: <a href="https://www.energy.gov/eere/ammto/advanced-manufacturing-office-fy20-critical-materials-foa-selections">ABTC was awarded a competitive grant supporting a $4.5 million project</a> from the U.S. DOE for the demonstration of its battery-grade lithium hydroxide production from Nevada claystone resources, with federal contributions of $2.27 million.</li>
<li>October 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-for-57m-grant-from-us-doe-for-construction-of-commercial-scale-lithium-hydroxide-refinery/">ABTC was awarded a competitive grant supporting a $115 million project</a> from the U.S. DOE to construct a commercial-scale lithium hydroxide refinery, with a federal contribution of $57.7 million.</li>
</ul>
These battery recycling technologies were developed in-house by the ABTC R&amp;D, project management, and engineering team members, many of whom were previously members of the founding Tesla Gigafactory design and engineering teams. &nbsp;ABTC intends to utilize these significant experiences in collaboration with project partners to scale processes and bring first-of-kind commercial-scale facilities online and leveraging this expertise to de-risk ABTC's commercialization of this second battery recycling facility.
As ABTC has now completed the technical and economic evaluations and been selected for this competitive grant award, it will next enter the grant award contracting phase of this process with an expected project kickoff in 2025.

ABAT

American Battery Technology Secures $150M US DOE Grant, Expanding Battery Recycling Facility

Owens & Minor Has Appointed Jonathan Leon As Executive Vice President And Chief Financial Officer, Effective Immediately

Chicago-based Motorola Solutions (MSI) will release its fourth-quarter and full-year results on February 8. Given the strong demand for its products and solutions, the company has bolstered its revenue and earnings estimates for fiscal 2023. Therefore, should investors consider buying the stock now? Read on to learn my view… Motorola Solutions, Inc. (<a href="https://stocknews.com/stock/MSI/">MSI</a>) is scheduled to report fourth-quarter and full-year results on February 8. Wall Street expects MSI's revenue and EPS for the quarter to increase year-over-year. In this piece, I have discussed why it could be wise to wait for a better entry point in the stock despite the expected rise in its revenue and earnings.
For the fourth quarter, MSI's EPS and revenue are expected to increase 0.9% and 4.1% year-over-year to $3.63 and $2.82 billion, respectively. The company has a solid earnings history, having beaten the consensus estimate in each of the trailing four quarters.
Post its third quarter results, MSI's Chairman and CEO Greg Brown said, "Q3 was another strong quarter, with record third-quarter revenue, earnings and cash flow. Safety and security have never been more important, and we continue to see robust demand, which drove our record Q3 backlog. As a result, we're again raising our revenue and earnings expectations for the full year."
MSI's revenues in the fourth quarter are expected to be boosted by higher growth in the Products and Systems Integration and Services and Software segments. The company ended the third quarter with a record backlog of $14.30 billion, which is 6% or $764 million higher than the prior-year quarter.
Its Products and Systems Integration segment's backlog was up $62 million or 1%, driven by solid demand in North America. Similarly, the Software and Services segment backlog was up $702 million or 8%, driven by increases in multi-year software and services contracts in North America, partially offset by revenue recognition for the Airwave contract.
For the fourth quarter, the company forecasted revenue growth of approximately 4% over the prior-year quarter. Its non-GAAP EPS is expected to come between $3.60 and $3.65. For the full year 2023, its revenue is expected to now come between $9.930 billion and $9.945 billion, up from the previous guidance of $9.875 billion and $9.900 billion.
The company also revised its fiscal 2023 guidance for non-GAAP EPS from between $11.40 and $11.48 to between $11.65 and $11.70. On December 18, 2023, MSI announced the acquisition of IPVideo, the creator of the HALO Smart Sensor. The acquisition reinforces MSI's commitment to improving safety and security by offering a cost-effective sensor that is easy to deploy and operate for enterprises of all sizes.
MSI's executive VP and CTO Mahesh Saptharishi said, "With its powerful sensor capabilities, HALO extends our end-to-end physical security offering by integrating a non-video threat detection product into our safety and security ecosystem."
Also, during the fourth quarter, MSI unveiled the LTE-enabled V500 body camera, the latest addition to its mobile video portfolio that provides vital real-time field intelligence to emergency response. In addition, its board of directors announced an increase in its regular quarterly dividend by 11% to 98 cents per share, payable on January 12, 2024. The board also approved an increase of $2 billion to its existing share repurchase program.
Other developments during the quarter include the Essex County Fire and Rescue Service choosing MSI's command center technology, including Control Room Solution (CRS), for its call handling and emergency dispatch capabilities. Also, Japan's Narita International Airport expanded the reach and capacity of its mission-critical TETRA communications network with MSI's broadband push-to-talk communication service, WAVE PTX.
The company also notified that Arizona had selected Rave Alert to enable emergency notification and reverse 9-1-1 alerting in its 81 public safety answering points.
MSI's stock has gained 16.7% over the past six months and 26% over the past year to close the last trading session at $325.38.
Here's what you might want to consider ahead of its upcoming earnings release:
Robust Financials
MSI's net sales for the fiscal third quarter ended September 30, 2023, increased 7.7% year-over-year to $2.56 billion. Its net cash provided by operating activities rose 84% over the prior-year quarter to $714 million. The company's free cash flow increased 104.1% year-over-year to $649 million.
Its non-GAAP net earnings attributable to MSI increased 6.4% year-over-year to $547 million. Also, its non-GAAP EPS stood at $3.19, representing an increase of 6.3% year-over-year.
Favorable Analyst Estimates
Analysts expect MSI's EPS and revenue for fiscal 2023 to increase 13.1% and 9.2% year-over-year to $11.72 and $9.95 billion, respectively. Its fiscal 2024 EPS and revenue are expected to increase 8.2% and 5.7% year-over-year to $12.68 and $10.51 billion, respectively.
Stretched Valuation
In terms of forward non-GAAP P/E, MSI's 27.76x is 10.9% higher than the 25.05x industry average. Its 2.98x forward non-GAAP <a href="https://www.investopedia.com/terms/p/pegratio.asp">PEG</a> is 45.5% higher than the 2.05x industry average. Likewise, its 21.63x forward EV/EBIT is 6.6% higher than the 20.30x industry average.
High Profitability
In terms of the trailing-12-month EBITDA margin, MSI's 28.60% is 219.3% higher than the 8.96% industry average. Likewise, its 16.65x trailing-12-month levered FCF margin is 98.2% higher than the industry average of 8.40x. Also, its 24.74x trailing-12-month EBIT margin is 427.9% higher than the industry average of 4.69x.
POWR Ratings Reflect Uncertainty
MSI has an overall rating of C, equating to a Neutral in our <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. MSI has a D grade for Value, consistent with its stretched valuation. It has a B grade for Quality, in sync with its high profitability.
MSI's stock is trading below its 10-day moving average of $326.44 and above its 200-day moving average of $295.04, justifying its C grade for Momentum. Also, it has a C grade for Stability, consistent with its 0.93 beta.
MSI is ranked #13 out of 46 stocks in the <a href="https://stocknews.com/category/technology-communication-networking/">Technology – Communication/Networking</a> industry. <a href="https://stocknews.com/stock/MSI/">Click here</a> to access MSI's Growth, Stability, and Sentiment ratings.
Bottom Line
MSI expects to end fiscal 2023 on a solid note as it has raised its revenue and earnings estimate for the entire year. The company is seeing strong demand for its mission-critical technologies. It is currently witnessing strong demand for land mobile radio (LMR), video security, and access control hardware.
Despite the solid developments, MSI trades at an expensive valuation. Moreover, given its mixed stability and momentum, it could be wise to wait for a better entry point in the stock.
How Does Motorola Solutions, Inc. (MSI) Stack Up Against Its Peers?
MSI has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the <a href="https://stocknews.com/category/technology-communication-networking/">Technology – Communication/Networking</a> industry: Gilat Satellite Networks Ltd. (<a href="https://stocknews.com/stock/GILT/">GILT</a>), Ceragon Networks Ltd. (<a href="https://stocknews.com/stock/CRNT/">CRNT</a>), and Eutelsat Group (<a href="https://stocknews.com/stock/ETCMY/">ETCMY</a>). For exploring more Buy-rated Technology – Communication/Networking stocks, <a href="https://stocknews.com/category/technology-communication-networking/">click here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
MSI shares were unchanged in premarket trading Wednesday. Year-to-date, MSI has gained 3.93%, versus a 4.24% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Dipanjan Banchur</h2> <img src='https:/wp-content/uploads/2021/11/Dipanjan-Banchur_headshots_3.jpg' style="float:left; padding:5px;width:125px;">Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master's degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets.<a href="https://stocknews.com/authors/?author=dipanjan-banchur">More...</a>The post <a href=https://stocknews.com/news/msi-gilt-crnt-etcmy-motorola-solutions-msi-quarterly-earnings-what-to-watch-for/>Motorola Solutions (MSI) Quarterly Earnings: What to Watch For</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Motorola Solutions (MSI) Quarterly Earnings: What to Watch For

Eutelsat Group reports 1H results

Eutelsat Communications S.A. (EUTLF) Q2 2023 Earnings Call Transcript

Eutelsat Group signs multi-year, multimillion-dollar agreement with Intelsat

Eutelsat Group (EUTLF) Q3 2024 Sales/ Trading Statement Call

Eutelsat Group reports Q3 results

Eutelsat Group (EUTLF) Q4 2024 Earnings Call Transcript

Eutelsat and Cable Color extend partnership for broadcast services in Latin America

SoftBank partners with Eutelsat to integrate OneWeb LEOsServices into its offerings

SoftBank partners with Eutelsat to integrate OneWeb LEO services into its offerings

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Eutelsat Comms

Eutelsat Comms (ETCMY) Forecast

Eutelsat Comms (OTC:ETCMY) Stock, Quote.Headers.trade-ideas